| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,542 | 8,172 | 8,001 | 9,653 | | Cost of Revenue | 1,790 | 1,973 | 1,970 | 2,265 | | | Gross Profit | 5,752 | 6,199 | 6,031 | 7,388 | | | Operating Expenses | | Research Development | 2,169 | 2,009 | 2,168 | 2,320 | | Selling General and Administrative | 3,030 | 3,088 | 3,487 | 3,441 | | Non Recurring | (4) | 56 | (2) | 25,057 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 557 | 1,046 | 378 | (23,430) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,138 | 1,142 | (863) | 1,526 | | Earnings Before Interest And Taxes | 1,695 | 2,188 | (485) | (21,904) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,695 | 2,188 | (485) | (21,904) | | Income Tax Expense | (104) | 79 | 141 | 192 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,799 | 2,109 | (626) | (22,096) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,799 | 2,109 | (626) | (22,096) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,799 | $2,109 | ($626) | ($22,096) |
|
0.51% Nasdaq 0.00%
Income Statement
